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Several earlier investigators (1, 2) have shown
the presence of arginase in mammalian skin.
Mardashev and Semina (3) and Van Scott (4,5),
working independently, showed that a majority
of the arginase activity in human skin was local-
ized in the epidermis.
Block (6), Eckstein (7) and Wilkerson (8) have
shown arginine to be a major constituent of
keratin. The significance of arginase activity to
arginine incorporation into keratin is at present
unknown.
The present study is concerned with a more
intimate evaluation of levels of arginase activity
in normal epidermal tissues, and comparison of
these levels to those found in epidermal tissues
in pathological conditions wherein disturbances
of normal keratin synthesis may occur.
MATERIALS AND METHODS
Collection of tissues. Scales from lesions of
desquamatory skin diseases were obtained either
by scraping the involved areas of skin with a
scalpel or by collecting from the bed of the pa-
tient scales which had been casually shed. In
all cases scales were collected during control
periods when therapy consisted of local applica-
tions of an ointment made of equal parts of
Aquaphor® and water. The use of soap and water
on the skin was prohibited during this time.
Stratum corneum of uninvolved skin of the
trunk of patients with psoriasis, and of normal
individuals, was obtained by scraping the skin
surface with a penknife, after first dry-shaving
the skin with a razor to remove all hair.
Stratum corneum of normal plantar skin was
obtained by scraping the skin surface with a
knife, or was removed as calluses by means of a
razor blade.
Normal epidermis was obtained from surgical
specimens of skin from the abdomen and breast.
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Mucous membrane of the esophagus, interior
buccal surface and vagina were obtained at
autopsy.
Basal cell carcinoma was obtained from surgi-
cal specimens.
Preparation of tissues. Scales were dehydrated
by lyophilization, defatted with ether, and ground
in a Wiley mifi fitted with a 60 mesh screen. The
powdered tissue was then passed through sieves1
of 100, 200, and 325 mesh to secure correspond-
ingly smaller sized particles.
Normal epidermis was separated from the
corium by the stretch method (9). The epidermis
was then lyophilized, defatted, ground and
sieved as described above.
Basal cell carcinoma tissue was separated from
the dermal connective tissue by gently mas-
saging the tumor tissue through a 60 mesh screen.
A smear preparation of the tissue that passed
through the screen was stained with hematoxylin-
eosin and microscopically examined. This prep-
aration was found to consist almost entirely of
basal cells, only trace amounts of connective
tissue being present. The tissue was then dried,
defatted, ground and sieved as described above.
Mucous membrane was separated from the
submucosal connective tissue by the stretch
method and was dried, defatted, ground and
sieved in the usual manner.
Arginase assay. Two types of arginase activity
were determined, potential and native. Potential
arginase activity was obtained by first incubating
ten milligrams of powdered tissue in 8 ml. of
0.05 M MnC12 for one hour at 50° C.; the argi-
nine hydrolysis was carried out at 37° C. for ten
minutes following the addition of 2 ml. of 1.7 M
arginine, pH 9.5. The reaction was terminated by
the addition of 2 ml. of 1.2 M 112S04; the reaction
1 U. S. Standard Sieve Series, Fisher Scientific
Co. The size of the holes in the four sieves were as
follows
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flask was immediately placed in an ice bath. An
aliquot was taken for the determination of urea
by the urease2 method of Krebs and Henseleit
(10). The carbon dioxide was measured mano-
metrically at pH 5.0 in the Warburg apparatus
at 38° C., according to standard procedure (11).
Native activity was measured without prior
activation of the enzyme with MnCl2; the tissue
was incubated, instead, with water for one hour
at 50° C.
Endogenous urea was determined by measuring
the urea present in an aqueous suspension of
powdered tissue. Any additional urea that was
endogenously formed during the incubations was
also determined (by omitting the substrate).
Substrate controls, omitting only the tissue,
were run for both potential and native arginase
determinations. A boiled enzyme control was
carried out by boiling the tissue in water for fif-
teen minutes before determining potential ac-
tivity.
Arginase activity was expressed as the milli-
grams of urea nitrogen formed per 100 grams of
dry, defatted tissue, resulting from the hydrolysis
of arginine upon incubation for ten minutes at
370 C.
Ornithine was assayed by the method of
Chinard (13). The acid ninhydrin solution was
made fresh the day of its intended use.
The enzymatic reactions discussed are:
(1) arginine hydrolysis:
HN
1111
C—N--CH2---CH2---CH2—CH—COOH
NH2 NH2
arginine
RESULTS
Effect of particle size on arginase activity. The
standard 60 mesh screen furnished with the Wiley
mill was initially used in preparation of the stand-
ard tissue powder. This powder, consisting of all
sized particles that passed through the 60 mesh,
gave variable values for arginase activity. Repro-
ducibility of the values seemed to be dependent
upon thorough mixing of the powders. For this
reason particles of more uniform size, obtained
by further passing the powder through screens of
smaller sized openings, were used. The arginase
activity for each particle size was then found to
be reproducible. Moreover, as suspected, the
smaller sized particles gave higher arginase values
(Table I). The data indicate the necessity for
using smaller sized particles in measuring enzyme
activity in some tissues (e.g. scales from lesions
of psoriasis and mycosis fungoides). The arginase
activity of callus appears to reach a maximum
when particles passing through the 100 mesh
sieve are used. No increased enzyme activity in
normal epidermis was found when particles
smaller than those passing through the 60 mesh
were used.
Optimum incubation time for activation of the
enzyme and hydrolysis of the substrate. Mohamed
and Greenberg (12), in their investigation of
arginase activities of several different tissues,
recommended that each type of tissue be indi-
vidually evaluated for optimal incubation time
with manganous chloride in order to obtain maxi-
mal activation of the enzyme. In the present work
both calluses and psoriasis scales were incubated
with manganous chloride for periods varying from
fifteen minutes to eight hours, but no difference
in degree of activation of the enzyme was found.
An incubation time of one hour was used rou-
tinely thereafter.
The optimum time for hydrolysis to occur at
maximum velocity was also determined. Periods
of hydrolysis of 3, 6, 9, 12, and 15 minutes gave
results that showed the reaction for both calluses
and psoriasis scales to be zero order during this
(2) urea hydrolysis:
NH2
C=0 + 1120 —* 2N113 + CO2
I
ph5
NH2
NH2
arginaseMn C +
ph9.5
NH2
urea
H2N—C112—C112----C112—CH—000H
NH2
ornithine
'Urease, obtained from the Hartman and Led-
don Co. of Philadelphia, Pa., was prepared fresh
as a 1% solution in 0.3 M acetate buffer, pH 5.
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TABLE I
Variation of arginase activity* with
particle size
Sieve Mesh
Psoriasis
Scales
(MS.)
Callus
(MS.)
Scales of
Mycosis
Fungoides
Epidermis
60
100
200
325
Regu-
lart
250
149
74
44
16,200
21,200
32,400
35,800
23,400
17,800
21,600
22,400
—
21,900
12,700
—
21,500
—
11,400
—
9,500
—
* Potential activity, expressed as mgms. urea
nitrogen per 100 gms. dry, defatted tissue.
t Regular includes all sized particles passing
through 60 mesh sieve before further sieving.
TABLE II
Arginase activity* in various epidermat tissues
.
peclfllen PotentialActivity
Native
Activity
Normal epidermis 8,700 —
Normal epidermis 7,050 670
Normal epidermis 8,600 —
Normal epidermis 3,900 275
Normal epidermis 6,250 —
Normal epidermis 14,950 1,245
Str. corneum, normal (VS) 7,760 —
Str. corneum, uninvolved, from
patient with psoriasis (MS). ... 3,160 310
Plantar callus (pooled) 22,400 1,600
Plantar callus from verrucae
vulgares 19,700 1,760
Mucous membrane (esophagus). . 755 —
Mucous membrane (esophagus). . 2,840 1,670
Mucous membrane (vagina) 350 —
Basal cell carcinoma 3,275 175
Scales, psoriasis (MS) 35,900 2,310
Scales, psoriasis (AA) 48,700 2,580
Scales, psoriasis (MD) 92,500 2,860
Scales, psoriasis (LP) 36,900 2,905
Scales, psoriasis (JW) 23,800 2,685
Scales, psoriasis (AS) 34,500 2,915
Scales exfol. erythroderma (PR).. 20,900 1,150
Scales, nummular eczema (LL)... 12,975 500
Scales, ichthyosiform erythro-
derma (RH) 27,625 2,250
Scales, ichthyosis (MC) 19,100 1,190
* Expressed as mgms. urea nitrogen per 100
gms. dry, defatted tissue.
period. A reaction time of ten minutes was se-
lected for all subsequent analyses.
Comparison of arginase activity of different tis-
sues. The arginase activities found in various tis-
sues are listed in Table II. The particle size used
in each case was that which gave the maximal
activity. Each value listed is the average of results
of two or more determinations which agreed with
each other within five per cent.
In all cases the potential arginase activity was
much greater than the native activity, and usu-
ally was found to be ten to thirty times that of
the native activity.
Both the potential and native arginase activi-
ties were greater in psoriasis scales than in all
other tissues, with the exception of scales from
skin involved with ichthyosiform erythroderma.
Activities of normal epidermis ranged between
3,900 and 14,950, while those of psoriasis scales
ranged from 23,800 to 92,500. The arginase values
of stratum corneum from both normal skin and
uninvolved skin of patients with psoriasis were
comparable to those of normal epidermis.
The arginase activity of all mucous membranes
was lower than that of normal epidermis.
It was of interest to compare the arginase
activity of stratum corneum from different kera-
tin forming areas in a single individual. Compari-
son of the potential and native values listed in
Table III shows that the arginase activity of
psoriasis scales exceeds by more than tenfold the
activity found in the stratum corneum of the
uninvolved skin. The activity of stratum cor-
neum of plantar skin was six times that of the
stratum corneum of skin of the trunk.
Site of the enzyme. Psoriasis scales and normal
epidermis were homogenized and the potential
arginase activity in both the supernatant and
the particulate fraction determined. The super-
natant contained less than 10% of the expected
activity while the particulate showed 90% of the
expected activity. This suggested the enzyme to
have a nuclear location rather than cytoplasmic.
Tests were also performed on sonicated scales.
TABLE III
Arginase activity* of different keratin forming areas
on the same individual (MS)
Potential Native
Psoriasis scales (trunk) 35,900 2,310
Str. corneum of uninvolved skin
(trunk) 3,160 310
Str. corneum of uninvolved
plantar skin 17,700 1,710
* Expressed as mgms. urea nitrogen per 100 gins.
of dry, defatted tissue.
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TABLE IV
Apparent inhibition of urease reaction by products of the arginase reaction
Experimental Calculated
1 2 3 1 — 2 % inhibition
Substrate
,L1 CO2
10 pM urea + A*
469
A
294
10 pM urea
216 175
18.7
Substrate
p1 CO2
10 pM urea + 3-A
337
3A
140
10 pM urea
219 197
10.0
Substrate
pl CO2
5pM urea + A
356
A
294
5 pM urea
109 62
43.2
Substrate
z1 CO2
5pM urea + 3A
228
A
140
5 pM urea
110 88
20.0
* A 1 ml. (0.5 mgm. tissue) of supernatant at end of arginase reaction.
TABLE V
Influence of normal epidermis upon the arginase activity* of psoriasis scales
Tissue Experimental Calculated Dierence % Inhibition
A. Psoriasis (AS) 34,900 3A — 17,450
B. Normal epidermis 6,240 B — 3,120
C. Mixed tissues (A + B) 15,100 3A + B 20,570 5,470 26.5
* Expressed as mgms. urea nitrogen per 100 gms. dry, defatted tissue.
TABLE VI
Influence of psoriasis scales and normal epidermis
on urease reaction
Reactants Poduced
10pM urea
10 pM urea + 0.5 mgms. Psor. (AS)...
10 pM urea + 1.0 mgms. Psor. (AS)...
10 pM urea + 2.0 mgms. Psor. (AS)...
10 pM urea + 4.0 mgms. Psor. (AS)...
10 pM urea + 0.5 mgms. Normal epid..
222.0
224.5
206.5
212.5
208.5
213.0
Examination of the whole sonicate showed no
loss of arginase activity. Further analyses showed
the activity to be distributed in a ratio of 1:6,
supernatant to particulate.
Inhibition of urease. Somewhat different values
for arginase activity were found when different
methods were used to examine the products of
reaction. (In the regular method urea was exam-
med by the urease reaction, while in the other
ornithine was assayed colorimetrically.) The re-
sult obtained by the regular method was approxi-
mately 30% lower than that obtained by the
ornithine assay method. In searching for an ex-
planation of these results a known amount of
urea was determined by the urease method, in
the presence of supernatant of the arginase reac-
tion. The results listed in Table IV show that
indeed an inhibition of urease activity results
upon addition of the arginase reaction super-
natant.
Inhibition of arginase by norma' epidermis. One
of the possibilities to account for the low arginase
activity of epidermis would be the presence in
epidermis of an enzyme inhibitor. This possibility
was tested by carrying out mixed tissue experi-
ments. The results of these experiments (Table V)
show that indeed this is the case since the argi-
nase activity of psoriasis scales is diminished by
the presence of normal epidermis. Possible inhi-
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bition of urease by epidermis was ruled out by
enzymatic (urease) determination of known quan-
tities of urea in the presence of known quantities
of epidermis. No evidence of a urease inhibitor in
epidermis was found (Table VI). The results also
indicate that the urease inhibition shown in
Table IV is due to the reaction products rather
than due to an inhibitory substance within the
tissue per se.
A brown precipitate, thought to be manganous
dioxide, was formed during the arginine hydroly-
sis. In order to ascertain whether such a precipi-
tate would remove sufficient manganous ions from
solution and thus reduce the hydrolytic activity
of the enzyme, hydrolysis was performed in a
nitrogen atmosphere. The formation of mangan-
ous dioxide was thus eliminated, but no increase
of enzyme activity was found.
DISCUSSION
Potential activity V8. nativeactivity. The question
may be raised whether the activity of an enzyme
found under in vitro conditions reliably reflects
the actual activity of the enzyme in vivo, particu-
larly when the in vitro activity is measured after
maximal activation of the enzyme with metallic
ions in concentrations not normally found under
physiologic conditions. For this reason activity of
arginase was determined both after maximal
activation by incubation with manganous ion,
and without such activation. The activities were
termed potential and native respectively. Com-
parison of the activities found in each tissue
specimen reveals that there is no fixed ratio be-
tween potential and native activity. It would
seem likely that the native activities more accu-
rately represent the true in vivo function of the
enzyme, and would be more reliable for this pur-
pose than the potential activities. From this point
of view then, the data indicate that the actual
in vivo activity of arginase (native activity) is
greater in scales of psoriasis than in any other
tissue examined. Whether this is due to a greater
amount of the enzyme, as the high potential ac-
tivities might suggest, or whether it is due to the
absence of an inhibitor such as found in normal
epidermis cannot be established from the data.
Scales from the patient with ichthyosiform
erythroderma had elevated arginase values, simi-
lar to psoriasis scales. This is perhaps not sur-
prising since the histologic changes in the skin of
the patient used in this study closely resembled
those of psoriasis, particularly in the degree of
persistence of nuclei in the stratum corneum
(parakeratosis). As arginase is thought to reside
mainly in the nucleus, it is entirely possible that
increased arginase activity may be directly related
to parakeratosis.
Particle size and cell permeability. The smaller
sized particles of tissue powder required to obtain
maximal values of arginase activity in scales of
psoriasis may be due to diminished permeability
of the cells in that tissue. By means of an ocular
micrometer, diameters of cells of psoriasis scales
were microscopically measured in smear prepara-
tions stained with hematoxylin. The average
diameter was estimated to be approximately 25
microns. Using this size as prototypal, the number
of cells comprising different sized particles was
calculated. Three dimensional schematic dia-
grams of the particles show that a direct relation-
ship exists between arginase activity (data of
Table I) and the number of cells on the periphery
of the particle. This relationship does not exist in
epidermis, suggesting that cells of this tissue are
more permeable than those of psoriasis scales.
Comparison of arginase activity in epidermal
tissues from various keratin forming areas. It
seems important to note and compare the argi-
nase activity found in mucous membrane, normal
epidermis, normal stratum corneum, and plantar
callus. Activity was least in mucous membrane,
greatest in plantar callus, and intermediate in
epidermis and stratum corneum of the trunk. The
comparative activities suggest that activity of
the enzyme may be proportionate to degree of
keratinization occurring in the tissue concerned.
The difference between plantar callus and nor-
ma! stratum corneum of the trunk is to be em-
phasized. In addition to this enzymatic difference,
other chemical differences can be found. For
example, plantar callus contains considerably
more arginine than stratum corneum of the trunk
(unpublished data). If these differences reflect
true relative metabolic activities, then it becomes
essential to consider these tissues individually at
all times. The use of pkzniar callus as a normal
control tissue for comparison to pathological horny
layers from areas of the body other than the soles
would seem to entail the use of invalid assumptions.
Arginase inhibitor in normal epidermis. The
arginase inhibitor found to be present in normal
epidermis, and active in lowering the arginase
activity of psoriasis scales, may be of considerable
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importance. This inhibitor is apparently either
absent in scales of psoriasis, or present in quanti-
ties insufficient to alter to any extent the activity
of arginase contained therein. To further interpret
the significance of arginase and its regulation in
psoriasis requires further study of the enzyme's
role in the process of normal keratinization.
SUMMARY
1. Potential and native arginase activities of
normal and pathological epidermal tissues were
measured.
2. Factors in accurate measurement of argi-
nase activity are discussed. The need for small
particle size of tissue is emphasized, particularly
in studying tissues where cell impermeability is
a factor.
3. Arginase activity was found to be signifi-
cantly higher in psoriasis scales than in normal
stratum corneum and normal epidermis.
4. Major differences were found in arginase
activity of epidermal tissues from various keratin
forming areas. The significance of this dissimi-
larity is discussed.
5. Normal epidermis was found to inhibit the
high arginase activity of psoriasis scales.
Addendum: Further work has indicated that
whereas arginase is inhibited in some specimens
of epidermis obtained from surgically removed
skin, in other surgical specimens no such inhi-
bition has been found. An explanation for this
apparent discrepancy in results has not yet been
determined.
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